Carl Shaprio is a panelist on “Intellectual Property and Dominant Firms.” CRA is sponsoring the leading forum that’s for lawyers, policymakers, corporate executives, economists, and academics to address current issues in competition law and policy.
For more information, click here.
What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...